You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 132 No. 1, July 1973 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ARTICLES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (16)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Type IV Hyperlipoproteinemia

A Critical Appraisal

Gustav Schonfeld, MD; David J. Kudzma, MD

Arch Intern Med. 1973;132(1):55-62.


Abstract



Sensitivity to carbohydrate, obesity, glucose intolerance, and hyperinsulinism have been separately assigned causative roles in primary type IV hyperlipoproteinemia. These conditions were inconstant enough in 18 consecutive men with type IV disease as to suggest that none is fundamental to the disorder. Endogenous triglyceridemia increased variably with carbohydrate surfeit, disappeared rarely with carbohydrate restriction, and showed imposing contributions from fed fat—findings indicating that the disorder is not necessarily carbohydrate-dependent. Levels of endogenous triglyceride before and after high-carbohydrate feeding lacked correlation with obesity, found in only 44% of the patients. Glucose intolerance occurred in 50%; hyperinsulinism occurred more regularly (seven of nine patients studied). As none of these conditions is common to all cases of type IV disease, it is likely that they play only contributory roles, intensifying the fundamental abnormality, or that the type IV phenotype has protean causes.



Author Affiliations



St. Louis; San Antonio, Tex

From the Department of Medicine, Washington University School of Medicine, St. Louis (Dr. Schonfeld), and Wilford Hall, USAF Medical Center, and the University of Texas Medical School at San Antonio, San Antonio, Tex.


Footnotes



Received for publication April 25, 1972; accepted May 4.

Reprint requests to Section of Endocrinology and Metabolism, Department of Medicine, University of Texas Medical School at San Antonio, 7703 Floyd Curl Dr, San Antonio TX 78284 (Dr. Kudzma).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Common Hyperlipoproteinemias: An Understanding of Disease Mechanisms and Their Control
FISHER and TRUITT
ANN INTERN MED 1976;85:497-508.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1973 American Medical Association. All Rights Reserved.